| Literature DB >> 35627386 |
Pedro Teixeira1,2, Nuno Pinto2, Isabel Henriques3, Marta Tacão1,2.
Abstract
Carbapenems are antibiotics of pivotal importance in human medicine, the efficacy of which is threatened by the increasing prevalence of carbapenem-resistant Enterobacterales (CRE). Urban ponds may be reservoirs of CRE, although this hypothesis has been poorly explored. We assessed the proportion of CRE in urban ponds over a one-year period and retrieved 23 isolates. These were submitted to BOX-PCR, PFGE, 16S rDNA sequencing, antibiotic susceptibility tests, detection of carbapenemase-encoding genes, and conjugation assays. Isolates were affiliated with Klebsiella (n = 1), Raoultella (n = 11), Citrobacter (n = 8), and Enterobacter (n = 3). Carbapenemase-encoding genes were detected in 21 isolates: blaKPC (n = 20), blaGES-5 (n = 6), and blaVIM (n = 1), with 7 isolates carrying two carbapenemase genes. Clonal isolates were collected from different ponds and in different campaigns. Citrobacter F6, Raoultella N9, and Enterobacter N10 were predicted as pathogens from whole-genome sequence analysis, which also revealed the presence of several resistance genes and mobile genetic elements. We found that blaKPC-3 was located on Tn4401b (Citrobacter F6 and Enterobacter N10) or Tn4401d (Raoultella N9). The former was part of an IncFIA-FII pBK30683-like plasmid. In addition, blaGES-5 was in a class 3 integron, either chromosomal (Raoultella N9) or plasmidic (Enterobacter N10). Our findings confirmed the role of urban ponds as reservoirs and dispersal sites for CRE.Entities:
Keywords: Enterobacterales; antibiotic resistance; carbapenemases; urban aquatic environments
Mesh:
Substances:
Year: 2022 PMID: 35627386 PMCID: PMC9141432 DOI: 10.3390/ijerph19105848
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Map depicting the location, designation and coordinates of the sampled ponds (P1–P5) and estuarine canal (E1). Green areas indicate the location of urban parks, while blue areas represent the Ria de Aveiro urban canals. The location of the municipal hospital is also denoted (H).
Features of CRE obtained from the urban ponds (P) and estuarine canal (E).
| Resistance Profile b | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Isolate | Sampling Site of Origin | Sampling Date | Phylogenetic Affiliation a | Typing Profiles c | Replicons | Integrase Gene | Carbapenemase Gene | PRL | TZP | FEP | CTX | CAZ | IPM | ETP | MEM | ATM | TE | TGC | AK | CIP | C | SXT | CN |
| F1 | P1 | Feb/19 |
| A-V | - |
|
| ||||||||||||||||
| F2 | P1 |
| A | - |
|
| |||||||||||||||||
| F3 | P1 |
| A-VII | IncN |
|
| |||||||||||||||||
| F4 | P1 |
| A-VI | IncL/M |
|
| |||||||||||||||||
| F5 | P1 |
| B-IX | - |
|
| |||||||||||||||||
| F6 | P1 |
| A-VIII | IncN; IncM1; IncFIA(HI1); IncFII(K); pKPC-CAV1321 |
|
| |||||||||||||||||
| S1 | P1 | Sept/19 |
| D-I | - |
|
| ||||||||||||||||
| S3 | P1 |
| D | - |
|
| |||||||||||||||||
| S4 | P1 |
| D | - |
|
| |||||||||||||||||
| S5 | P1 |
| D | - |
|
| |||||||||||||||||
| O1 | P1 | Oct/19 |
| D-I | - |
|
| ||||||||||||||||
| O5 | P1 |
| D-II | - |
|
| |||||||||||||||||
| N1 | P1 | Nov/19 |
| E-III | IncFIA-FII |
| |||||||||||||||||
| N5 | P1 |
| C-X | IncN |
| ||||||||||||||||||
| N6 | P1 |
| A-V | IncN |
|
| |||||||||||||||||
| N8 | P1 |
| E-III | IncL/M |
| ||||||||||||||||||
| N9 | P1 |
| E-III | IncFIA-FII; CoI(MGD2); CoI(pHAD28) |
| ||||||||||||||||||
| N10 | P1 |
| G | CoI440I; IncFIB-FII; IncM1; IncN; IncX5; pKPC-CAV1321 |
| ||||||||||||||||||
| N11 | P3 |
| H | - | - | - | |||||||||||||||||
| N12 | E1 |
| E-IV | IncFIA-FII |
| ||||||||||||||||||
| N13 | E1 |
| E-III | - |
| ||||||||||||||||||
| N14 | P1 |
| F | - |
|
| |||||||||||||||||
| N15 | P3 |
| H | - | - | - | |||||||||||||||||
a Determined by BLAST using 16S rRNA gene. b PRL, piperacillin; TZP, piperacillin–tazobactam; FEP, cefepime; CTX, cefotaxime; CAZ, ceftazidime; IPM, imipenem; ETP, ertapenem; MEM, meropenem; ATM, aztreonam; TE, tetracycline; TGC, tigecycline; AK, amikacin; CIP, ciprofloxacin; C, chloramphenicol; SXT, trimethoprim–sulfamethoxazole; CN, gentamicin (dark grey, resistant; white, susceptible). c BOX profiles are designated with letters and PFGE profiles with Roman numerals; A hyphen is displayed whenever no replicon, carbapenemase gene, and integrase gene were detected.
MICs of carbapenems and cephalosporins for Citrobacter isolates F1 and N6, transconjugants E. coli J53::KPC, and recipient strain E. coli J53.
| MIC, mg/L (Susceptibility) | |||||
|---|---|---|---|---|---|
| ETP | MEM | IPM | CAZ | CTX | |
| 0.012 (S) | 0.016 (S) | 0.38 (S) | 0.047 (S) | 0.016 (S) | |
| >32 (R) | 16 (R) | >32 (R) | >256 (R) | 12 (R) | |
| 0.125 (S) | 0.5 (S) | 2 (S) | 12 (R) | 3 (R) | |
| 2 (R) | 8 (IR) | >32 (R) | 64 (R) | 6 (R) | |
| 0.75 (R) | 0.5 (S) | 8 (R) | 32 (R) | 4 (R) | |
ETP, ertapenem; MEM, meropenem; IPM, imipenem; CAZ, ceftazidime; CTX, cefotaxime (R, resistant; IR, intermediate; S, susceptible).
Putative ARGs and plasmids predicted by CARD and PlasmidFinder, respectively, in CRE isolates.
| Isolates | |||
|---|---|---|---|
| Drug Class/Predicted Plasmids | |||
| Beta-lactam resistance |
|
|
|
|
|
|
| |
|
|
|
| |
|
| |||
|
| |||
|
| |||
|
| |||
| Chloramphenicol resistance |
| ||
| Aminoglycoside resistance |
|
| |
|
| |||
|
| |||
| Macrolides resistance |
|
|
|
| Quinolones resistance |
| ||
| Sulfonamides resistance |
|
|
|
| Diaminopyrimidine resistance |
|
| |
| Tetracycline resistance |
| ||
| Fosfomycin resistance |
|
| |
| Resistance to other antibiotics |
| ||
| Plasmid Content | IncFIA(HI1) | Col(MGD2) | CoI440I |
| IncFII(K) | Col(pHAD28) | IncFIB(pECLA) | |
| IncM1 | CoI440I | IncM1 | |
| IncN | IncFIA/FII (pBK30683) | IncN | |
| pKPC-CAV1321 | IncX5 | ||
| pKPC-CAV1321 | |||
Figure 2Genetic context of blaKPC-3 in C. freundii F6 (A), E. kobei N10 (B), E. coli BK32602 (C) (KU295134), K. pneumoniae strain 39427 (D) (CP054266), and K. pneumoniae FCF3SP (E) (CP004367).
Figure 3Genetic context of blaGES-5 in E. kobei N10 (A), E. cloacae Ecl-W (B) (MN180807), K. oxytoca strain H143640707 (C) (KX946994), and E. cloacae LIM73 (D) (HE616889).